Compare Hims and Hers Health Inc (HIMS) vs Kinder Morgan Inc (KMI) Price & Performance

Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.

The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.

Kinder Morgan (KMI) trades at $31.82, down 1.06% today, with a bullish technical signal and strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters, showing revenue growth from $15.1B in 2024 to $16.9B in 2025, with net income rising to $3.06B. Analyst consensus targets $37.20, suggesting 17% upside potential, supported by a $10B project backlog and growing natural gas demand from LNG exports and data centers.

KMI presents a compelling investment case with stable fee-based revenues, dividend yield, and growth opportunities in energy infrastructure. Key risks include energy market volatility, high debt levels ($29.66B long-term debt), and interest rate sensitivity. The stock offers value with reasonable valuation multiples (P/E 20.53, P/S 3.94) and positive analyst sentiment despite competitive pressures in the midstream sector.